First Foundation Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,377
Closed -$327K 393
2022
Q4
$327K Sell
1,377
-521
-27% -$111K 0.02% 294
2022
Q3
$380K Sell
1,898
-1,568
-45% -$299K 0.02% 260
2022
Q2
$506K Sell
3,466
-8,568
-71% -$1.22M 0.02% 249
2022
Q1
$1.97M Sell
12,034
-2,430
-17% -$370K 0.07% 135
2021
Q4
$2.45M Buy
14,464
+600
+4% +$112K 0.08% 119
2021
Q3
$2.62M Buy
13,864
+1,035
+8% +$194K 0.1% 110
2021
Q2
$2.17M Buy
12,829
+1,155
+10% +$169K 0.08% 135
2021
Q1
$1.65M Buy
+11,674
New +$1.76M 0.07% 152

Other funds holding ALNY